(320 ILCS 50/5)
Sec. 5. Findings. The General Assembly finds:
(1) Senior citizens identify pharmaceutical assistance as the single most critical factor to their health, well‑being, and continued independence.
(2) The State of Illinois currently operates 2 pharmaceutical assistance programs that benefit seniors: (i) the program of pharmaceutical assistance under the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act and (ii) the Aid to the Aged, Blind, or Disabled program under the Illinois Public Aid Code. The State has been given authority to establish a third program, SeniorRx Care, through a federal Medicaid waiver.
(3) Each year, numerous pieces of legislation are filed seeking to establish additional pharmaceutical assistance benefits for seniors or to make changes to the existing programs.
(4) Establishment of a pharmaceutical assistance review committee will ensure proper coordination of benefits, diminish the likelihood of duplicative benefits, and ensure that the best interests of seniors are served.
(5) In addition to the State pharmaceutical assistance programs, several private entities, such as drug manufacturers and pharmacies, also offer prescription drug discount or coverage programs.
(6) Many seniors are unaware of the myriad of public and private programs available to them.
(7) Establishing a pharmaceutical clearinghouse with a toll‑free hot‑line and local outreach workers will educate seniors about the vast array of options available to them and enable seniors to make an educated and informed choice that is best for them.
(8) Estimates indicate that almost one‑third of senior citizens lack prescription drug coverage. The federal government, states, and the pharmaceutical industry each have a role in helping these uninsured seniors gain access to life‑saving medications.
(9) The State of Illinois has recognized its obligation to assist Illinois' neediest seniors in purchasing prescription medications, and it is now time for pharmaceutical manufacturers to recognize their obligation to make their medications affordable to seniors.
(Source: P.A. 92‑594, eff. 6‑27‑02.) |
(320 ILCS 50/10)
Sec. 10. Definitions. In this Act:
"Manufacturer" includes:
(1) An entity that is engaged in (a) the production, |
| preparation, propagation, compounding, conversion, or processing of prescription drug products (i) directly or indirectly by extraction from substances of natural origin, (ii) independently by means of chemical synthesis, or (iii) by combination of extraction and chemical synthesis; or (b) the packaging, repackaging, labeling or re‑labeling, or distribution of prescription drug products. | |
(2) The entity holding legal title to or possession |
| of the national drug code number for the covered prescription drug. | |
The term does not include a wholesale distributor of drugs, drugstore chain organization, or retail pharmacy licensed by the State.
"Prescription drug" means a drug that may be dispensed only upon prescription by an authorized prescriber and that is approved for safety and effectiveness as a prescription drug under Section 505 or 507 of the Federal Food, Drug and Cosmetic Act.
"Senior citizen" or "senior" means a person 65 years of age or older.
(Source: P.A. 92‑594, eff. 6‑27‑02.) |
(320 ILCS 50/15)
Sec. 15. Senior Pharmaceutical Assistance Review Committee.
(a) The Senior Pharmaceutical Assistance Review Committee is created. The Committee shall consist of 17 members as follows:
(1) Twelve members appointed as follows: 2 members of |
| the General Assembly and 1 member of the general public, appointed by the President of the Senate; 2 members of the General Assembly and 1 member of the general public, appointed by the Minority Leader of the Senate; 2 members of the General Assembly and 1 member of the general public, appointed by the Speaker of the House of Representatives; and 2 members of the General Assembly and 1 member of the general public, appointed by the Minority Leader of the House of Representatives. These members shall serve at the pleasure of the appointing authority. |
|
(2) The Director of Aging or his or her designee.
(3) The Director of Revenue or his or her designee.
(4) The Director of Healthcare and Family Services or |
|
(5) The Secretary of Human Services or his or her |
|
(6) The Director of Public Health or his or her |
|
(b) Members appointed from the general public shall represent the following associations, organizations, and interests: statewide membership‑based senior advocacy organizations, pharmaceutical manufacturers, pharmacists, dispensing pharmacies, physicians, and providers of services to senior citizens. No single organization may have more than one representative appointed as a member from the general public.
(c) The President of the Senate and Speaker of the House of Representatives shall each designate one member of the Committee to serve as co‑chairs.
(d) Committee members shall serve without compensation or reimbursement for expenses.
(e) The Committee shall meet at the call of the co‑chairs, but at least quarterly.
(f) The Committee may conduct public hearings to gather testimony from interested parties regarding pharmaceutical assistance for Illinois seniors, including changes to existing and proposed programs.
(f‑5) The Committee may review federal legislation with regard to e‑prescribing to determine what provisions, if any, would improve health care in Illinois.
(f‑6) The Committee may conduct public hearings to gather testimony regarding federal procedure for pandemic preparedness and response to determine whether or not the State should update its preparedness procedures and tactics.
(g) The Committee may advise appropriate State agencies regarding the establishment of proposed programs or changes to existing programs. The State agencies shall take into consideration any recommendations made by the Committee.
(h) The Committee shall report to the General Assembly and the Governor annually or as it deems necessary regarding proposed or recommended changes to pharmaceutical assistance programs that benefit Illinois seniors and any associated costs of those changes.
(h‑5) The Committee may conduct public hearings to gather testimony from interested parties regarding prescription drug abuse to determine whether the State should increase penalties against those engaged in conduct potentially harmful to Illinois residents, particularly those under age 25. In order to do this, the Committee may review guidelines from State universities addressing prescription drug abuse.
(i) In the event that a prescription drug benefit is added to the federal Medicare program, the Committee shall make recommendations for the realignment of State‑operated senior prescription drug programs so that Illinois residents qualify for at least substantially the same level of benefits available to them prior to implementation of the Medicare prescription drug benefit, provided that a resident remains eligible for such a State‑operated program. The Committee shall report its recommendations to the General Assembly and the Governor by January 1, 2005.
(Source: P.A. 95‑331, eff. 8‑21‑07; 96‑1183, eff. 7‑22‑10.) |
(320 ILCS 50/20)
Sec. 20. Senior Health Assistance Program.
(a) The Senior Health Assistance Program is created within the Department on Aging, to become operational within 90 days after the effective date of this Act. The Senior Health Assistance Program shall provide outreach and education to senior citizens on available prescription drug coverage and discount programs.
(b) The Senior Health Assistance Program shall operate a Clearinghouse for all information regarding prescription drug coverage programs available to senior citizens in Illinois. The Clearinghouse shall operate in conjunction with the Department's toll‑free senior information program.
(c) The purposes of the Clearinghouse include, but are not limited to:
(1) Maintaining information on public and private |
| prescription assistance programs for Illinois seniors. | |
(2) Educating citizens on available public and |
| private prescription assistance programs. | |
(3) Educating seniors on how to make an informed |
| decision about participation in prescription drug assistance programs. | |
(d) The Clearinghouse has the following duties:
(1) Provide a one‑stop resource for all information |
| for seniors regarding public and private prescription drug discount and coverage programs. | |
(2) Perform outreach and education activities on |
| public and private prescription drug discount and coverage programs. | |
(3) Maintain a toll‑free telephone number staffed by |
| trained customer service representatives. | |
(4) Maintain measurable data to identify the |
| progress and success of the program, including, but not limited to, the number of individuals served, the type of assistance received, and overall program evaluation. | |
(e) The Department shall work cooperatively with other Departments that fund senior health assistance, including assistance with prescription drugs, to ensure maximum coordination.
(Source: P.A. 92‑594, eff. 6‑27‑02.) |
(320 ILCS 50/25)
Sec. 25. Study of catastrophic pharmaceutical assistance coverage.
(a) The Illinois Comprehensive Health Insurance Board shall study a catastrophic pharmaceutical assistance coverage option. The Board may contract with a private entity for the completion of all or part of the study. Specifically, the study shall:
(1) Assess the need for a catastrophic |
| pharmaceutical assistance coverage option, including information on the number of individuals in need of such a benefit. | |
(2) Estimate the cost of providing a catastrophic |
| pharmaceutical assistance coverage option through the Illinois Comprehensive Health Insurance Plan or another public or private entity. | |
(3) Recommend ways to create a catastrophic |
| pharmaceutical assistance coverage option. | |
(b) The Board may accept donations, in trust, from any legal source, public or private, for deposit into a specially created trust account and for expenditure, without the necessity of being appropriated, solely for the purpose of conducting all or part of the study.
(c) The Board may enter into intergovernmental agreements with other State agencies for the purpose of conducting all or part of the study.
(d) The Board shall issue a report with recommendations to the Governor and the General Assembly by January 1, 2003.
(Source: P.A. 92‑594, eff. 6‑27‑02.) |
(320 ILCS 50/5)
Sec. 5. Findings. The General Assembly finds:
(1) Senior citizens identify pharmaceutical assistance as the single most critical factor to their health, well‑being, and continued independence.
(2) The State of Illinois currently operates 2 pharmaceutical assistance programs that benefit seniors: (i) the program of pharmaceutical assistance under the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act and (ii) the Aid to the Aged, Blind, or Disabled program under the Illinois Public Aid Code. The State has been given authority to establish a third program, SeniorRx Care, through a federal Medicaid waiver.
(3) Each year, numerous pieces of legislation are filed seeking to establish additional pharmaceutical assistance benefits for seniors or to make changes to the existing programs.
(4) Establishment of a pharmaceutical assistance review committee will ensure proper coordination of benefits, diminish the likelihood of duplicative benefits, and ensure that the best interests of seniors are served.
(5) In addition to the State pharmaceutical assistance programs, several private entities, such as drug manufacturers and pharmacies, also offer prescription drug discount or coverage programs.
(6) Many seniors are unaware of the myriad of public and private programs available to them.
(7) Establishing a pharmaceutical clearinghouse with a toll‑free hot‑line and local outreach workers will educate seniors about the vast array of options available to them and enable seniors to make an educated and informed choice that is best for them.
(8) Estimates indicate that almost one‑third of senior citizens lack prescription drug coverage. The federal government, states, and the pharmaceutical industry each have a role in helping these uninsured seniors gain access to life‑saving medications.
(9) The State of Illinois has recognized its obligation to assist Illinois' neediest seniors in purchasing prescription medications, and it is now time for pharmaceutical manufacturers to recognize their obligation to make their medications affordable to seniors.
(Source: P.A. 92‑594, eff. 6‑27‑02.) |
(320 ILCS 50/10)
Sec. 10. Definitions. In this Act:
"Manufacturer" includes:
(1) An entity that is engaged in (a) the production, |
| preparation, propagation, compounding, conversion, or processing of prescription drug products (i) directly or indirectly by extraction from substances of natural origin, (ii) independently by means of chemical synthesis, or (iii) by combination of extraction and chemical synthesis; or (b) the packaging, repackaging, labeling or re‑labeling, or distribution of prescription drug products. | |
(2) The entity holding legal title to or possession |
| of the national drug code number for the covered prescription drug. | |
The term does not include a wholesale distributor of drugs, drugstore chain organization, or retail pharmacy licensed by the State.
"Prescription drug" means a drug that may be dispensed only upon prescription by an authorized prescriber and that is approved for safety and effectiveness as a prescription drug under Section 505 or 507 of the Federal Food, Drug and Cosmetic Act.
"Senior citizen" or "senior" means a person 65 years of age or older.
(Source: P.A. 92‑594, eff. 6‑27‑02.) |
(320 ILCS 50/15)
Sec. 15. Senior Pharmaceutical Assistance Review Committee.
(a) The Senior Pharmaceutical Assistance Review Committee is created. The Committee shall consist of 17 members as follows:
(1) Twelve members appointed as follows: 2 members of |
| the General Assembly and 1 member of the general public, appointed by the President of the Senate; 2 members of the General Assembly and 1 member of the general public, appointed by the Minority Leader of the Senate; 2 members of the General Assembly and 1 member of the general public, appointed by the Speaker of the House of Representatives; and 2 members of the General Assembly and 1 member of the general public, appointed by the Minority Leader of the House of Representatives. These members shall serve at the pleasure of the appointing authority. |
|
(2) The Director of Aging or his or her designee.
(3) The Director of Revenue or his or her designee.
(4) The Director of Healthcare and Family Services or |
|
(5) The Secretary of Human Services or his or her |
|
(6) The Director of Public Health or his or her |
|
(b) Members appointed from the general public shall represent the following associations, organizations, and interests: statewide membership‑based senior advocacy organizations, pharmaceutical manufacturers, pharmacists, dispensing pharmacies, physicians, and providers of services to senior citizens. No single organization may have more than one representative appointed as a member from the general public.
(c) The President of the Senate and Speaker of the House of Representatives shall each designate one member of the Committee to serve as co‑chairs.
(d) Committee members shall serve without compensation or reimbursement for expenses.
(e) The Committee shall meet at the call of the co‑chairs, but at least quarterly.
(f) The Committee may conduct public hearings to gather testimony from interested parties regarding pharmaceutical assistance for Illinois seniors, including changes to existing and proposed programs.
(f‑5) The Committee may review federal legislation with regard to e‑prescribing to determine what provisions, if any, would improve health care in Illinois.
(f‑6) The Committee may conduct public hearings to gather testimony regarding federal procedure for pandemic preparedness and response to determine whether or not the State should update its preparedness procedures and tactics.
(g) The Committee may advise appropriate State agencies regarding the establishment of proposed programs or changes to existing programs. The State agencies shall take into consideration any recommendations made by the Committee.
(h) The Committee shall report to the General Assembly and the Governor annually or as it deems necessary regarding proposed or recommended changes to pharmaceutical assistance programs that benefit Illinois seniors and any associated costs of those changes.
(h‑5) The Committee may conduct public hearings to gather testimony from interested parties regarding prescription drug abuse to determine whether the State should increase penalties against those engaged in conduct potentially harmful to Illinois residents, particularly those under age 25. In order to do this, the Committee may review guidelines from State universities addressing prescription drug abuse.
(i) In the event that a prescription drug benefit is added to the federal Medicare program, the Committee shall make recommendations for the realignment of State‑operated senior prescription drug programs so that Illinois residents qualify for at least substantially the same level of benefits available to them prior to implementation of the Medicare prescription drug benefit, provided that a resident remains eligible for such a State‑operated program. The Committee shall report its recommendations to the General Assembly and the Governor by January 1, 2005.
(Source: P.A. 95‑331, eff. 8‑21‑07; 96‑1183, eff. 7‑22‑10.) |
(320 ILCS 50/20)
Sec. 20. Senior Health Assistance Program.
(a) The Senior Health Assistance Program is created within the Department on Aging, to become operational within 90 days after the effective date of this Act. The Senior Health Assistance Program shall provide outreach and education to senior citizens on available prescription drug coverage and discount programs.
(b) The Senior Health Assistance Program shall operate a Clearinghouse for all information regarding prescription drug coverage programs available to senior citizens in Illinois. The Clearinghouse shall operate in conjunction with the Department's toll‑free senior information program.
(c) The purposes of the Clearinghouse include, but are not limited to:
(1) Maintaining information on public and private |
| prescription assistance programs for Illinois seniors. | |
(2) Educating citizens on available public and |
| private prescription assistance programs. | |
(3) Educating seniors on how to make an informed |
| decision about participation in prescription drug assistance programs. | |
(d) The Clearinghouse has the following duties:
(1) Provide a one‑stop resource for all information |
| for seniors regarding public and private prescription drug discount and coverage programs. | |
(2) Perform outreach and education activities on |
| public and private prescription drug discount and coverage programs. | |
(3) Maintain a toll‑free telephone number staffed by |
| trained customer service representatives. | |
(4) Maintain measurable data to identify the |
| progress and success of the program, including, but not limited to, the number of individuals served, the type of assistance received, and overall program evaluation. | |
(e) The Department shall work cooperatively with other Departments that fund senior health assistance, including assistance with prescription drugs, to ensure maximum coordination.
(Source: P.A. 92‑594, eff. 6‑27‑02.) |
(320 ILCS 50/25)
Sec. 25. Study of catastrophic pharmaceutical assistance coverage.
(a) The Illinois Comprehensive Health Insurance Board shall study a catastrophic pharmaceutical assistance coverage option. The Board may contract with a private entity for the completion of all or part of the study. Specifically, the study shall:
(1) Assess the need for a catastrophic |
| pharmaceutical assistance coverage option, including information on the number of individuals in need of such a benefit. | |
(2) Estimate the cost of providing a catastrophic |
| pharmaceutical assistance coverage option through the Illinois Comprehensive Health Insurance Plan or another public or private entity. | |
(3) Recommend ways to create a catastrophic |
| pharmaceutical assistance coverage option. | |
(b) The Board may accept donations, in trust, from any legal source, public or private, for deposit into a specially created trust account and for expenditure, without the necessity of being appropriated, solely for the purpose of conducting all or part of the study.
(c) The Board may enter into intergovernmental agreements with other State agencies for the purpose of conducting all or part of the study.
(d) The Board shall issue a report with recommendations to the Governor and the General Assembly by January 1, 2003.
(Source: P.A. 92‑594, eff. 6‑27‑02.) |
